Brain α‐Ketoglutarate Dehydrogenase Complex: Kinetic Properties, Regional Distribution, and Effects of Inhibitors
- 1 November 1986
- journal article
- research article
- Published by Wiley in Journal of Neurochemistry
- Vol. 47 (5), 1376-1386
- https://doi.org/10.1111/j.1471-4159.1986.tb00768.x
Abstract
The substrate and cofactor requirements and some kinetic properties of the α-ketoglutarate dehydrogenase complex (KGDHC; EC 1.2.4.2, EC 2.3.1.61, and EC 1.6.4.3) in purified rat brain mitochondria were studied. Brain mitochondrial KGDHC showed absolute requirement for α-ketoglutarate, CoA and NAD, and only partial requirement for added thiamine pyrophosphate, but no requirement for Mg2+ under the assay conditions employed in this study. The pH optimum was between 7.2 and 7.4, but, at pH values below 7.0 or above 7.8, KGDHC activity decreased markedly. KGDHC activity in various brain regions followed the rank order: cerebral cortex > cerebellum ≧ midbrain > striatum = hippocampus > hypothalamus > pons and medulla > olfactory bulb. Significant inhibition of brain mitochondrial KGDHC was noted at pathological concentrations of ammonia (0.2–2 mM). However, the purified bovine heart KGDHC and KGDHC activity in isolated rat heart mitochondria were much less sensitive to inhibition. At 5 mM both β-methylene-D,L-aspartate and D,L-vinylglycine (inhibitors of cerebral glucose oxidation) inhibited the purified heart but not the brain mitochondrial enzyme complex. At approximately 10 μM, calcium slightly stimulated (by 10–15%) the brain mitochondrial KGDHC. At concentrations above 100 μM, calcium (IC50= 1 mM) inhibited both brain mitochondrial and purified heart KGDHC. The present results suggest that some of the kinetic properties of the rat brain mitochondrial KGDHC differ from those of the purified bovine heart and rat heart mitochondrial enzyme complexes. They also suggest that the inhibition of KGDHC by ammonia and the consequent effect on the citric acid cycle fluxes may be of pathophysiological and/or pathogenetic importance in hyperammonemia and in diseases (e.g., hepatic encephalopathy, inborn errors of urea metabolism, Reye's syndrome) where hyperammonemia is a consistent feature. Brain accumulation of calcium occurs in a number of pathological conditions. Therefore, it is possible that such a calcium accumulation may have a deleterious effect on KGDHC activity.Keywords
This publication has 58 references indexed in Scilit:
- Pyruvate Dehydrogenase Activity in Regions of the Rat Brain During Postnatal DevelopmentJournal of Neurochemistry, 1984
- The Activities of Some Energy‐Metabolising Enzymes in Nonsynaptic (Free) and Synaptic Mitochondria Derived from Selected Brain RegionsJournal of Neurochemistry, 1984
- Properties and Regional Distribution of Pyruvate Dehydrogenase Kinase in Rat BrainJournal of Neurochemistry, 1984
- Ammonia metabolism in the CNSProgress in Neurobiology, 1983
- Activities of the Mitochondrial NAD-Linked Isocitric Dehydrogenase in Different Regions of the Rat BrainGerontology, 1982
- On the role of the calcium transport cycle in heart and other mammalian mitochondriaFEBS Letters, 1980
- Regulation of the citric acid cycle in mammalian systemsFEBS Letters, 1980
- Cerebral blood flow and metabolism in chronically hyperammonemic rats: Effect of an acute ammonia challengeAnnals of Neurology, 1978
- Mechanism of inhibitory action of ammonia on the respiration of rat-liver mitochondriaBiochimica et Biophysica Acta, 1962
- THE REGULATION OF γ‐AMINOBUTYRIC ACID METABOLISM IN CEREBRAL CORTEX MITOCHONDRIAJournal of Neurochemistry, 1961